ArticleMolecular therapy. Nucleic acids2023

High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cells.

Francesca Tasca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.